Businesskahapon94K+ searches
[Analysis] Genome & Company’s additional ₩7 bil. cosmetics investment raises strategy, shareholder value questions
Kinuwestyon ng ilang analysts ang resource allocation ng kumpanya mula sa drug R&D papuntang skincare.
1 Stories Loaded